UniProt ID | MP2K4_MOUSE | |
---|---|---|
UniProt AC | P47809 | |
Protein Name | Dual specificity mitogen-activated protein kinase kinase 4 | |
Gene Name | Map2k4 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 397 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to proinflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14.. | |
Protein Sequence | MAAPSPSGGGGSGGGGGTPGPIGPPASGHPAVSSMQGKRKALKLNFANPPVKSTARFTLNPNTTGVQNPHIERLRTHSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERTVEVACYVCKILDQMPATPSSPMYVD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAPSPSGG ------CCCCCCCCC | 28.25 | - | |
5 | Phosphorylation | ---MAAPSPSGGGGS ---CCCCCCCCCCCC | 27.29 | 30482847 | |
52 | Ubiquitination | NFANPPVKSTARFTL CCCCCCCCCCEEEEE | 48.11 | 22790023 | |
54 | Phosphorylation | ANPPVKSTARFTLNP CCCCCCCCEEEEECC | 19.01 | - | |
56 | Asymmetric dimethylarginine | PPVKSTARFTLNPNT CCCCCCEEEEECCCC | 25.77 | - | |
56 | Methylation | PPVKSTARFTLNPNT CCCCCCEEEEECCCC | 25.77 | 24129315 | |
76 | Phosphorylation | PHIERLRTHSIESSG CCHHHHHHCEECCCC | 25.27 | 22324799 | |
78 | Phosphorylation | IERLRTHSIESSGKL HHHHHHCEECCCCCC | 27.69 | 26824392 | |
81 | Phosphorylation | LRTHSIESSGKLKIS HHHCEECCCCCCCCC | 42.60 | 25266776 | |
82 | Phosphorylation | RTHSIESSGKLKISP HHCEECCCCCCCCCH | 27.44 | 26745281 | |
88 | Phosphorylation | SSGKLKISPEQHWDF CCCCCCCCHHHHCCC | 22.31 | 25521595 | |
96 | Phosphorylation | PEQHWDFTAEDLKDL HHHHCCCCHHHHHHH | 27.02 | 24925903 | |
101 | Acetylation | DFTAEDLKDLGEIGR CCCHHHHHHHHHHCC | 64.33 | 23954790 | |
218 | Acetylation | VKALNHLKENLKIIH HHHHHHHHHHHEEEC | 36.69 | 23954790 | |
244 | S-nitrosocysteine | RSGNIKLCDFGISGQ CCCCEEECCCCCCHH | 3.28 | - | |
244 | S-nitrosylation | RSGNIKLCDFGISGQ CCCCEEECCCCCCHH | 3.28 | 16418269 | |
255 | Phosphorylation | ISGQLVDSIAKTRDA CCHHHHHHHHHHCCC | 19.57 | 22322096 | |
259 | Phosphorylation | LVDSIAKTRDAGCRP HHHHHHHHCCCCCCC | 25.43 | 22322096 | |
264 | Glutathionylation | AKTRDAGCRPYMAPE HHHCCCCCCCCCCCC | 4.20 | 24333276 | |
276 | Phosphorylation | APERIDPSASRQGYD CCCCCCCCHHHCCCC | 34.82 | 25521595 | |
278 | Phosphorylation | ERIDPSASRQGYDVR CCCCCCHHHCCCCCH | 29.49 | 25521595 | |
294 | Phosphorylation | DVWSLGITLYELATG HHHHHCCCHHHHHHC | 22.84 | 28576409 | |
389 | Phosphorylation | ILDQMPATPSSPMYV HHHCCCCCCCCCCCC | 20.17 | 25521595 | |
391 | Phosphorylation | DQMPATPSSPMYVD- HCCCCCCCCCCCCC- | 42.60 | 25521595 | |
392 | Phosphorylation | QMPATPSSPMYVD-- CCCCCCCCCCCCC-- | 18.19 | 25521595 | |
395 | Phosphorylation | ATPSSPMYVD----- CCCCCCCCCC----- | 12.59 | 25521595 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
78 | S | Phosphorylation | Kinase | AKT1 | P31750 | PSP |
78 | S | Phosphorylation | Kinase | SGK1 | Q9WVC6 | PSP |
78 | S | Phosphorylation | Kinase | SGK1 | Q06226 | PSP |
78 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
255 | S | Phosphorylation | Kinase | MAP3K11 | Q16584 | GPS |
255 | S | Phosphorylation | Kinase | MAP3K12 | Q60700 | GPS |
259 | T | Phosphorylation | Kinase | MAP3K11 | Q16584 | GPS |
259 | T | Phosphorylation | Kinase | MAP3K12 | Q60700 | GPS |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MP2K4_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MK10_MOUSE | Mapk10 | physical | 15218018 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...